MUMBAI, India, Nov. 14 -- Intellectual Property India has published a patent application (202517094912 A) filed by Hadidianmoghaddam, Mostafa, Zanjan, Iran, on Oct. 2, for 'a combined and practical product based on targeted exercise, nutrition and medication.'
Inventor(s) include Hadidianmoghaddam, Mostafa.
The application for the patent was published on Nov. 14, under issue no. 46/2025.
According to the abstract released by the Intellectual Property India: "Diabetes, or blood sugar disease, is caused by the resistance of body cells to insulin. The prescribed medicine is prescribed despite the body's resistance to insulin, and this medicine prevents the rise of blood sugar to a large extent, but it does not eliminate insulin resistance, so specialist doctors recommend exercise and proper nutrition to patients when they prescribe the medicine. But this advice is not as precise as medicine and each patient follows it to some extent according to his taste so this advice is not as effective as possible. The imbalance between the three causes diabetes complications, and the more time passes, the more complicated this becomes. In this invention, we control type 1 and 2 diabetes and prevent its complications by strictly implementing the exercise and nutrition program along with the drug therapy administered by the doctor."
The patent application was internationally filed on Oct. 18, 2023, under International application No.PCT/IB2023/060516.
Disclaimer: Curated by HT Syndication.
